CN Stock MarketDetailed Quotes
300244 Dian Diagnostics Group
- 13.06
- -0.41-3.04%
Market Closed Nov 15 15:00 CST
8.16BMarket Cap-88243P/E (TTM)
13.60High13.02Low159.15KlotVolume13.48Open13.47Pre Close212.35MTurnover3.17%Turnover Ratio26.54P/E (Static)624.98MShares26.8052wk High1.16P/B6.55BFloat Cap8.6952wk Low16.16Limit Up501.46MShs Float85.55Historical High10.78Limit Down4.31%Amplitude1.98Historical Low0.71Dividend TTM13.34Avg Price77.49KlotAsk5.44%Div YieldTTM100Lot Size78.91KlotBid
Dian Diagnostics Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.05%9.26B | -9.12%6.22B | -8.01%2.97B | -33.89%13.41B | -34.15%10.29B | -36.37%6.84B | -30.48%3.23B | 55.03%20.28B | 67.37%15.63B | 85.68%10.75B |
| Operating revenue | -10.05%9.26B | -9.12%6.22B | -8.01%2.97B | -33.89%13.41B | -34.15%10.29B | -36.37%6.84B | -30.48%3.23B | 55.03%20.28B | 67.37%15.63B | 85.68%10.75B |
| Other operating revenue | ---- | -24.50%111.92K | ---- | -20.33%1.36M | ---- | --148.24K | ---- | -52.53%1.71M | ---- | --0 |
| Total operating cost | -5.42%8.49B | -3.88%5.72B | -0.05%2.78B | -26.26%12.24B | -25.52%8.98B | -25.80%5.95B | -20.24%2.78B | 49.79%16.6B | 58.19%12.05B | 65.33%8.02B |
| Operating cost | -3.67%6.66B | -1.70%4.5B | 3.06%2.21B | -27.71%9.21B | -24.85%6.91B | -25.09%4.57B | -17.56%2.15B | 57.80%12.75B | 60.47%9.2B | 65.89%6.11B |
| Operating tax surcharges | -16.21%29.42M | -13.31%20.16M | -9.16%9.94M | -18.03%46.04M | -10.60%35.11M | -11.65%23.25M | -13.31%10.95M | 20.84%56.17M | 23.20%39.28M | 31.84%26.32M |
| Operating expense | -1.14%876.61M | -4.86%560.5M | -0.58%260.75M | -13.37%1.38B | -20.81%886.71M | -23.55%589.12M | -32.75%262.26M | 31.94%1.6B | 43.50%1.12B | 63.31%770.64M |
| Administration expense | -15.95%547.06M | -9.68%389.71M | -13.81%169.02M | -25.31%947.07M | -34.02%650.88M | -36.61%431.49M | -34.97%196.11M | 14.41%1.27B | 53.37%986.53M | 66.62%680.74M |
| Financial expense | -10.43%151.79M | -14.41%98.82M | -16.52%50.89M | -26.03%220.61M | -23.92%169.47M | -22.34%115.45M | 4.08%60.96M | 37.13%298.24M | 49.99%222.75M | 43.03%148.66M |
| -Interest expense (Financial expense) | -21.51%155.36M | -20.47%107.1M | -19.48%54.89M | -8.78%250.6M | -0.66%197.94M | 5.81%134.67M | 32.83%68.17M | 19.34%274.73M | 37.40%199.26M | 32.01%127.28M |
| -Interest Income (Financial expense) | 43.24%-19.41M | 35.65%-15.28M | 3.47%-10.2M | -100.49%-41.76M | -100.67%-34.19M | -122.11%-23.74M | -100.83%-10.57M | 5.87%-20.83M | 8.41%-17.04M | -18.15%-10.69M |
| Research and development | -29.71%225.28M | -28.95%154.76M | -27.61%72.33M | -32.24%432.64M | -33.71%320.48M | -24.56%217.81M | -13.14%99.92M | 50.32%638.47M | 71.58%483.46M | 73.29%288.73M |
| Credit Impairment Loss | -0.28%-354.35M | -0.96%-254.66M | 20.67%-92.78M | -25.50%-383.08M | -43.11%-353.37M | -48.68%-252.24M | -26.11%-116.95M | -210.69%-305.23M | -195.19%-246.92M | -167.24%-169.65M |
| Asset Impairment Loss | 199.27%767.41K | -296.51%-2.63M | 61.61%-1.45M | 97.32%-16.74M | 61.16%-773.06K | 74.59%-663.67K | -473.85%-3.78M | -129.26%-624.02M | -16.59%-1.99M | -122.17%-2.61M |
| Other net revenue | -17.27%-331.01M | -124.97%-250.18M | -0.28%-93.17M | 62.28%-322.86M | -58.29%-282.26M | 25.37%-111.21M | -11.60%-92.91M | -434.13%-856.04M | -399.12%-178.32M | -258.57%-149.01M |
| Fair value change income | -162.53%-15.81M | -607.81%-16.15M | -222.71%-7.48M | 98.71%-726.62K | 238.57%25.28M | 116.81%3.18M | 28.03%6.09M | -167.47%-56.24M | -126.20%-18.24M | -118.31%-18.92M |
| Invest income | 1,353.03%9.18M | -95.20%4.97M | 45.84%-1.92M | -136.07%-17.6M | -97.96%632.09K | 473.51%103.39M | -339.48%-3.55M | -11.84%48.79M | -13.38%30.93M | -11.10%18.03M |
| -Including: Investment income associates | 10,913.30%12.64M | 843.46%3.51M | 28.51%-4.14M | -125.12%-6.72M | -100.48%-116.86K | -105.89%-472.2K | -2,757.89%-5.79M | -32.73%26.76M | -19.90%24.29M | -49.98%8.02M |
| Asset deal income | 236.44%2.48M | 288.82%2.92M | -95.88%163.3K | 68.06%-3.57M | -62.77%736.6K | 973.20%750.01K | 659.27%3.96M | -276.01%-11.18M | -41.32%1.98M | -103.44%-85.89K |
| Other revenue | -40.94%26.72M | -55.26%15.38M | -51.68%10.3M | 7.63%98.86M | -19.12%45.23M | 41.87%34.38M | 362.89%21.32M | 41.05%91.85M | 54.16%55.92M | -25.47%24.23M |
| Operating profit | -57.78%435.85M | -68.21%247.84M | -71.47%102.86M | -70.16%842.18M | -69.62%1.03B | -69.82%779.71M | -66.69%360.49M | 53.58%2.82B | 91.10%3.4B | 149.90%2.58B |
| Add:Non operating Income | 324.47%7.84M | 508.98%7.45M | 228.35%2.02M | 193.92%6.64M | -19.42%1.85M | -63.42%1.22M | -74.49%616.53K | -31.03%2.26M | -81.67%2.29M | -66.10%3.35M |
| Less:Non operating expense | 52.84%19.51M | -11.78%8.86M | -40.05%3.52M | -82.05%50.5M | -29.49%12.77M | 69.07%10.04M | 120.33%5.87M | 460.20%281.31M | 49.98%18.11M | 20.58%5.94M |
| Total profit | -58.47%424.17M | -68.03%246.44M | -71.47%101.37M | -68.61%798.33M | -69.80%1.02B | -70.13%770.9M | -67.16%355.24M | 42.02%2.54B | 90.17%3.38B | 148.46%2.58B |
| Less:Income tax cost | -47.18%121.49M | -53.75%73.81M | -75.12%24.97M | -68.18%216.74M | -55.25%230.01M | -59.84%159.6M | -39.23%100.39M | 121.57%681.09M | 81.08%514.01M | 151.82%397.39M |
| Net profit | -61.75%302.68M | -71.76%172.63M | -70.02%76.39M | -68.77%581.59M | -72.40%791.43M | -72.00%611.3M | -72.20%254.85M | 25.54%1.86B | 91.89%2.87B | 147.86%2.18B |
| Net profit from continuing operation | -61.75%302.68M | -71.76%172.63M | -70.02%76.39M | -68.77%581.59M | -72.40%791.43M | -72.00%611.3M | -72.20%254.85M | 25.54%1.86B | 91.89%2.87B | 147.86%2.18B |
| Less:Minority Profit | -34.05%171.83M | -36.15%100.89M | -43.73%53.22M | -35.99%274.13M | -40.79%260.55M | -47.97%158.01M | -41.95%94.58M | 33.54%428.28M | 68.11%440.02M | 97.38%303.71M |
| Net profit of parent company owners | -75.35%130.86M | -84.17%71.75M | -85.54%23.17M | -78.56%307.46M | -78.13%530.88M | -75.89%453.29M | -78.74%160.27M | 23.33%1.43B | 96.94%2.43B | 158.54%1.88B |
| Earning per share | ||||||||||
| Basic earning per share | -74.99%0.2118 | -84.05%0.1153 | -85.49%0.0371 | -78.64%0.4918 | -78.34%0.8468 | -76.11%0.7231 | -78.95%0.2557 | 22.84%2.3022 | 96.76%3.9093 | 158.29%3.0269 |
| Diluted earning per share | -74.99%0.2118 | -84.05%0.1153 | -85.47%0.0371 | -78.60%0.4918 | -78.26%0.8468 | -76.02%0.7229 | -78.88%0.2554 | 23.36%2.2983 | 99.46%3.8955 | 160.41%3.015 |
| Other composite income | -1.68K | -117.18 | -567.58 | -20.87K | ||||||
| Other composite income of parent company owners | ---1.68K | ---117.18 | ---567.58 | ---20.87K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -61.76%302.68M | -71.76%172.63M | -70.02%76.39M | -68.77%581.57M | -72.40%791.43M | -72.00%611.3M | -72.20%254.85M | 25.54%1.86B | 91.89%2.87B | 147.86%2.18B |
| Total composite income of parent company owners | -75.35%130.86M | -84.17%71.75M | -85.54%23.17M | -78.56%307.44M | -78.13%530.88M | -75.89%453.29M | -78.74%160.27M | 23.33%1.43B | 96.94%2.43B | 158.54%1.88B |
| Total composite income of minority owners | -34.05%171.83M | -36.15%100.89M | -43.73%53.22M | -35.99%274.13M | -40.79%260.55M | -47.97%158.01M | -41.95%94.58M | 33.54%428.28M | 68.11%440.02M | 97.38%303.71M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data